Priothera Sas

Priothera Sas company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Company Details

Employees
21
Founded
-
Address
57 Avenue Du Général De Gaulle, Saint Louis,68300,france
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Saint Louis
Looking for a particular Priothera Sas employee's phone or email?

Priothera Sas Questions

News

Priothera Strengthens Board with Appointment of Industry Veteran, Dr. Hans Menssen - GlobeNewswire

Priothera Strengthens Board with Appointment of Industry Veteran, Dr. Hans Menssen GlobeNewswire

Priothera appoints Jens Hasskarl as CMO - The Pharma Letter

Priothera appoints Jens Hasskarl as CMO The Pharma Letter

Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting - Yahoo Finance

Priothera to Present Trial in Progress Poster for Mocravimod at 2024 American Society of Hematology (ASH) Annual Meeting Yahoo Finance

Phase 2b/3 MO-TRANS Trial of Mocravimod Enrolls First Patients With AML - Targeted Oncology

Phase 2b/3 MO-TRANS Trial of Mocravimod Enrolls First Patients With AML Targeted Oncology

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments - PharmTech

Priothera Awarded €1.7M in Innovation Contest for Hematologic Malignancy Treatments PharmTech

Japan’s PMDA grants clearance for Priothera to commence AML therapy - Clinical Trials Arena

Japan’s PMDA grants clearance for Priothera to commence AML therapy Clinical Trials Arena

FDA grants second orphan drug designation to Priothera’s mocravimod - Pharmaceutical Technology

FDA grants second orphan drug designation to Priothera’s mocravimod Pharmaceutical Technology

Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies - Yahoo Finance

Priothera – US FDA grants Orphan Drug Designation to mocravimod to improve the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with hematologic malignancies Yahoo Finance

Irish biotech Priothera hires EuroAPI to make its small molecule - Chemical & Engineering News

Irish biotech Priothera hires EuroAPI to make its small molecule Chemical & Engineering News

Dublin’s Priothera raises €30m to develop leukaemia treatment - IDA Ireland

Dublin’s Priothera raises €30m to develop leukaemia treatment IDA Ireland

Priothera raises €30M to trial ex-Novartis' S1P drug in AML - Fierce Biotech

Priothera raises €30M to trial ex-Novartis' S1P drug in AML Fierce Biotech

Priothera - The Pharma Letter

Priothera The Pharma Letter

Top Priothera Sas Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant